Zacks Investment Research cut shares of CynergisTek (NYSEAMERICAN:CTEK) from a buy rating to a hold rating in a report released on Tuesday.

According to Zacks, “CynergisTek, Inc. provides cyber security and information management consulting in healthcare industry. It specializes in privacy, security, compliance and document management. The company’s service includes risk assessment, technical security, baseline security, information security program assessment, print security, vulnerability, architecture, penetration testing, social engineering and phishing and riskSonar assessment tool. CynergisTek Inc., formerly known as Auxilio, Inc., is headquartered in Mission Viejo, CA. “

Shares of CTEK opened at $4.73 on Tuesday. CynergisTek has a 12 month low of $3.23 and a 12 month high of $5.45.

CynergisTek (NYSEAMERICAN:CTEK) last issued its quarterly earnings data on Wednesday, November 7th. The company reported $0.23 EPS for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.09. The company had revenue of $19.22 million for the quarter, compared to analyst estimates of $18.65 million.

Several large investors have recently added to or reduced their stakes in CTEK. Bank of America Corp DE acquired a new position in shares of CynergisTek in the second quarter worth about $2,298,000. ARS Investment Partners LLC lifted its stake in shares of CynergisTek by 40.4% in the third quarter. ARS Investment Partners LLC now owns 463,180 shares of the company’s stock worth $1,783,000 after acquiring an additional 133,362 shares in the last quarter. Bridgeway Capital Management Inc. lifted its stake in shares of CynergisTek by 50.5% in the third quarter. Bridgeway Capital Management Inc. now owns 164,000 shares of the company’s stock worth $631,000 after acquiring an additional 55,000 shares in the last quarter. Vanguard Group Inc lifted its stake in shares of CynergisTek by 30.2% in the third quarter. Vanguard Group Inc now owns 98,036 shares of the company’s stock worth $377,000 after acquiring an additional 22,722 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of CynergisTek by 30.2% in the third quarter. Vanguard Group Inc. now owns 98,036 shares of the company’s stock worth $377,000 after acquiring an additional 22,722 shares in the last quarter.

About CynergisTek

Cynergistek, Inc provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program.

Featured Article: Should you buy a closed-end mutual fund?

Get a free copy of the Zacks research report on CynergisTek (CTEK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.